Dehaze develops early disease detection technology that identifies chronic conditions before symptoms appear, improving patient outcomes and quality of life.
Dehaze was founded in 2023 and provides data privacy compliant access to high-quality longitudinal data for research and analytics purposes. The company focuses on enabling organizations to securely access and utilize sensitive datasets while maintaining compliance with data protection regulations and privacy standards. By facilitating trusted and structured access to long-term data, dehaze supports data-driven innovation, research, and decision-making across industries that rely on secure and compliant data infrastructure.